Production & Manufacturing

Precision in pharmaceutical analysis is fundamental to ensuring that every therapeutic agent delivered to a patient meets the highest safety and efficacy standards. The implementation of high-grade spectrophotometers drug quality control workflows provides a scientific basis for quantifying chemical properties and physical characteristics with unmatched reliability. By leveraging advanced spectral data, manufacturers can validate formulations and detect impurities early in the production cycle, thereby reinforcing the integrity of the global supply chain, ensuring regulatory compliance, and protecting the well-being of patients around the world.

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard conversational tools, aiming to embed agentic AI capabilities directly into core workflows, including research, clinical...

eschbach has renamed its flagship enterprise software platform, Shiftconnector, to Seqonis, marking a new phase in the product’s development after two decades of expansion across pharmaceutical, chemical and process manufacturing industries. The announcement was made during the Pharma Manufacturing...

The rapid and profound maturation of the global biopharmaceutical sector is being clearly marked by cell and gene therapy manufacturing entering GMP era. This critical transition involves the large-scale implementation of rigorous and uncompromising Good Manufacturing Practice standards to ensure that these complex, "living" treatments are produced with a level of consistent quality and safety that meets international requirements. By adopting highly automated systems, closed-loop processing, and robust, data-driven regulatory frameworks, the industry is successfully overcoming the historical hurdles of scalability and biological variability, paving the way for these advanced therapies to reach much broader patient populations across the globe.

Color consistency is critical in pharmaceutical quality control (QC). Variations in tablet coatings, powders, liquids and packaging materials can indicate formulation inconsistencies, contamination risks or manufacturing deviations. To improve accuracy and reduce subjective visual inspection, pharmaceutical manufacturers increasingly rely...

A long-term development and commercial manufacturing agreement has been signed between Shilpa Medicare Limited and Switzerland-based NXI Therapeutics AG, extending the Indian pharmaceutical company’s role in global biologics and specialty therapeutics manufacturing. The agreement covers comprehensive chemistry, manufacturing and...

Swiss pharmaceutical company Novartis has started construction of a new manufacturing facility in Denton, Texas, as part of its previously announced $23 billion investment plan aimed at expanding research and production operations across the United States. The project, expected...